awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33754122-38B37712-267E-406A-9CFF-C1C6CAACC19B
Q33754122-38B37712-267E-406A-9CFF-C1C6CAACC19B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33754122-38B37712-267E-406A-9CFF-C1C6CAACC19B
Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinoma
P2860
Q33754122-38B37712-267E-406A-9CFF-C1C6CAACC19B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33754122-38B37712-267E-406A-9CFF-C1C6CAACC19B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53e411db9f67da61f9a01eb823c19cb30eb10bad
P2860
Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma.